全文获取类型
收费全文 | 2009篇 |
免费 | 152篇 |
国内免费 | 1篇 |
出版年
2022年 | 8篇 |
2021年 | 37篇 |
2020年 | 18篇 |
2019年 | 27篇 |
2018年 | 46篇 |
2017年 | 25篇 |
2016年 | 60篇 |
2015年 | 103篇 |
2014年 | 92篇 |
2013年 | 118篇 |
2012年 | 205篇 |
2011年 | 141篇 |
2010年 | 106篇 |
2009年 | 109篇 |
2008年 | 139篇 |
2007年 | 126篇 |
2006年 | 106篇 |
2005年 | 103篇 |
2004年 | 103篇 |
2003年 | 105篇 |
2002年 | 91篇 |
2001年 | 16篇 |
2000年 | 10篇 |
1999年 | 18篇 |
1998年 | 23篇 |
1997年 | 15篇 |
1996年 | 10篇 |
1995年 | 10篇 |
1994年 | 14篇 |
1993年 | 11篇 |
1992年 | 12篇 |
1991年 | 11篇 |
1990年 | 14篇 |
1989年 | 6篇 |
1988年 | 9篇 |
1987年 | 13篇 |
1986年 | 4篇 |
1985年 | 9篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1965年 | 3篇 |
排序方式: 共有2162条查询结果,搜索用时 31 毫秒
81.
82.
Abstract Growth of wild-type Escherichia coli strain MRE600 was severely affected up to 9 h following treatment with the anthracycline doxorubicin (15 μM), however, after 9 h, the cells became resistant. The onset of resistance coincided with some changes in the relative proportions of total saturated, monounsaturated and cyclopropane fatty acids. The anionic lipid content in E. coli strain HDL11 is under lac control and synthesis can be induced by incubation with the lac inducer IPTG. HDL11, with low levels of anionic phospholipid, was unaffected by doxorubicin (100 μM) over 9 h, with only slight inhibition of growth seen over 24 h. When the anionic lipid content of HDL11 was increased, there was a slight increase in the efficacy of doxorubicin, providing evidence for a membrane-based step in doxorubicin action. 相似文献
83.
84.
Carole L Hart George Davey Smith David J Hole Victor M Hawthorne 《BMJ (Clinical research ed.)》1999,318(7200):1725-1729
ObjectivesTo relate alcohol consumption to mortality.DesignProspective cohort study.Setting27 workplaces in the west of Scotland.Participants5766 men aged 35-64 when screened in 1970-3 who answered questions on their usual weekly alcohol consumption.ResultsRisk for all cause mortality was similar for non-drinkers and men drinking up to 14 units a week. Mortality risk then showed a graded association with alcohol consumption (relative rate compared with non-drinkers 1.34 (95% confidence interval 1.14 to 1.58) for 15-21 units a week, 1.49 (1.27 to 1.75) for 22-34 units, 1.74 (1.47 to 2.06) for 35 or more units). Adjustment for risk factors attenuated the increased relative risks, but they remained significantly above 1 for men drinking 22 or more units a week. There was no strong relation between alcohol consumption and mortality from coronary heart disease after adjustment. A strong positive relation was seen between alcohol consumption and risk of mortality from stroke, with men drinking 35 or more units having double the risk of non-drinkers, even after adjustment.ConclusionsThe overall association between alcohol consumption and mortality is unfavourable for men drinking over 22 units a week, and there is no clear evidence of any protective effect for men drinking less than this.
Key messages
- Results from a large cohort study of employed Scottish men showed different relations between alcohol consumption and mortality than previous studies
- There was no relation between mortality from coronary heart disease and alcohol consumption once adjustments were made for potential confounding factors
- There was a strong relation with mortality from stroke; drinkers of over 35 units a week had double the risk of mortality compared with non-drinkers
- Some but not all of this could be accounted for by alcohol related increases in blood pressure
- Overall, risk of all cause mortality was higher in men drinking 22 or more units a week
85.
Beaumont C 《Médecine sciences : M/S》2004,20(1):68-72
Iron metabolism in mammals requires a complex and tightly regulated molecular network. The classical view of iron metabolism has been challenged over the past ten years by the discovery of several new proteins, mostly Fe (II) iron transporters, enzymes with ferro-oxydase (hephaestin or ceruloplasmin) or ferri-reductase (Dcytb) activity or regulatory proteins like HFE and hepcidin. Furthermore, a new transferrin receptor has been identified, mostly expressed in the liver, and the ability of the megalin-cubilin complex to internalise the urinary Fe (III)-transferrin complex in renal tubular cells has been highlighted. Intestinal iron absorption by mature duodenal enterocytes requires Fe (III) iron reduction by Dcytb and Fe (II) iron transport through apical membranes by the iron transporter Nramp2/DMT1. This is followed by iron transfer to the baso-lateral side, export by ferroportin and oxidation into Fe (III) by hephaestin prior to binding to plasma transferrin. Macrophages play also an important role in iron delivery to plasma transferrin through phagocytosis of senescent red blood cell, heme catabolism and recycling of iron. Iron egress from macrophages is probably also mediated by ferroportin and patients with heterozygous ferroportin mutations develop progressive iron overload in liver macrophages. Iron homeostasis at the level of the organism is based on a tight control of intestinal iron absorption and efficient recycling of iron by macrophages. Signalling between iron stores in the liver and both duodenal enterocytes and macrophages is mediated by hepcidin, a circulating peptide synthesized by the liver and secreted into the plasma. Hepcidin expression is stimulated in response to iron overload or inflammation, and down regulated by anemia and hypoxia. Hepcidin deficiency leads to iron overload and hepcidin overexpression to anemia. Hepcidin synthesis in response to iron overload seems to be controlled by the HFE molecule. Patients with hereditary hemochromatosis due to HFE mutation have impaired hepcidin synthesis and forced expression of an hepcidin transgene in HFE deficient mice prevents iron overload. These results open new therapeutic perspectives, especially with the possibility to use hepcidin or antagonists for the treatment of iron overload disorders. 相似文献
86.
The role of Ca(2+)-permeable AMPA receptors in pain processing has not been extensively studied. In this issue of Neuron, Hartmann et al. show that altering the levels of these receptors has consequences for inflammatory pain hypersensitivity but not acute pain processing. 相似文献
87.
88.
89.
Recently we described the structures of two new bromotyrosine-derived alkaloids that inhibit the detoxification enzyme mycothiol-S-conjugate amidase (MCA) from Mycobacterium tuberculosis. Here we describe a concise total synthesis of bromotyrosine oxime 1. The six-step synthesis of 1 utilized a trifluoromethyloxazole intermediate, whose hydrolysis product underwent alkylation and coupling to agmatine to give the inhibitor in approximately 40% overall yield. Oxime 1 inhibited MCA and its homolog AcGI deacetylase with IC(50) values of 30 and 150 microM, respectively. 相似文献
90.
Vaisburg A Bernstein N Frechette S Allan M Abou-Khalil E Leit S Moradei O Bouchain G Wang J Woo SH Fournel M Yan PT Trachy-Bourget MC Kalita A Beaulieu C Li Z MacLeod AR Besterman JM Delorme D 《Bioorganic & medicinal chemistry letters》2004,14(1):283-287
A variety of omega-substituted alkanoic acid (2-amino-phenyl)-amides were designed and synthesized. These compounds were shown to inhibit recombinant human histone deacetylases (HDACs) with IC(50) values in the low micromolar range and induce hyperacetylation of histones in whole cells. They induced expression of p21WAF1/Cip1 and caused cell-cycle arrest in human cancer cells. Compounds in this class showed efficacy in human tumor xenograft models. 相似文献